Anzeige
Mehr »
Dienstag, 27.01.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A416MF | ISIN: US09061H4065 | Ticker-Symbol:
NASDAQ
26.01.26 | 21:58
2,425 US-Dollar
-6,01 % -0,155
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOMERICA INC Chart 1 Jahr
5-Tage-Chart
BIOMERICA INC 5-Tage-Chart

Aktuelle News zur BIOMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.01.Biomerica, Inc. Q2 Loss Widens-
14.01.Biomerica reports Q2 results1
14.01.Biomerica, Inc.: Biomerica Reports Second Quarter Fiscal 2026 Financial Results106Operating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the "Company")...
► Artikel lesen
14.01.BIOMERICA INC - 10-Q, Quarterly Report-
23.12.25Biomerica-Aktie steigt stark nach Festlegung der Medicare-Vergütung für Reizdarm-Test1
23.12.25Medicare to pay $300 for Biomerica's IBS test starting January 20261
23.12.25Biomerica, Inc.: Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods IBS Test1
16.12.25BIOMERICA INC - 8-K, Current Report-
BIOMERICA Aktie jetzt für 0€ handeln
11.12.25Egyptian drug authority approves Biomerica's cancer screening portfolio2
11.12.25Biomerica, Inc.: Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio2
25.11.25Biomerica, Inc.: Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS2
06.11.25Biomerica, Inc.: Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand2
16.10.25Biomerica, Inc.: Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S.344- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy...
► Artikel lesen
15.10.25Biomerica GAAP EPS of $0.00, revenue of $1.4M1
15.10.25Biomerica, Inc.: Biomerica Reports First Quarter Fiscal 2026 Financial Results174Reported Improved Gross Margin from Contribution from Higher-Margin Product MixOperating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company's...
► Artikel lesen
14.10.25BIOMERICA INC - 10-Q, Quarterly Report1
08.10.25Former LabCorp Diagnostics CEO Gary Huff joins Biomerica board3
08.10.25Biomerica, Inc.: Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors3
08.10.25BIOMERICA INC - 8-K, Current Report3
26.09.25BIOMERICA INC - 10-K/A, Annual Report1
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1